INTRODUCTION
Recent intense interest has focused on the molecular factors which regulate cell proliferation. Although this remains a central issue in cell biology, an understanding of the regulatory factors is also critical for therapeutic interventions in the various pathobiological conditions associated with excessive cellular proliferation. During hepatic cirrhosis, experimental and clinical morphologic studies have suggested that an 'activated' nonparenchymal hepatic sinusoidal Ito cell or a related myofibroblast increases in number and eventually surrounds the developing hepatic nodules, which are infiltrated with interstitial collagen bundles (Ballardini et al., 1983; Minato et al., 1983; Takahara et al., 1988) .
This activation/transformation process is characterized by an alteration in the Ito cell phenotype, with the expression of smooth-muscle a-actin and the PDGF receptor (Friedman & Arthur, 1989; Ramadori et al., 1989; Rockey et al., 1990) . Recent studies involving non-hepatic cells suggest that smoothmuscle a-actin expression occurs during the transformation to an ' activated' pathological phenotype which is associated with increased cellular proliferation and collagen production (Skalli et al., 1989) . The expression of the PDGF receptor may be causally related to the aforementioned cellular proliferation, since recent models in vivo of injury and fibrosis have found increases in PDGF and implicated a central role for this mesenchymal mitogen (Chen & Rabinovitch, 1989; Pierce et al., 1989a,b) .
The factors which specifically regulate Ito-cell proliferation are poorly understood, but recent evidence suggests that both endogenous and exogenous vitamin A and TGF/J may play regulatory roles (Shiratori et al., 1987; Russell et al., 1988; Davis, 1988; Davis & Vucic, 1988 Davis et al., 1990; Meyer et al., 1990) . The current study explores modulation by retinoic acid and TGF/? of the Ito-cell mitogenic response to PDGF and their associated alterations in smooth-muscle a-actin and PDGF-receptor abundance and activation.
MATERIALS AND METHODS

Chemicals
Retinoic acid used in the cell-culture experiments (final concn. 1 M) was prepared as stock 1 mm solutions in 100 % ethanol and stored under nitrogen in brown bottles at -20°C for less than 1 week. Control cultures treated with an equivalent volume of vehicle alone (final concn. 0.1 %) were indistinguishable from untreated cells. TGF, used in cell-culture experiments (1 ng/ml) and in e.l.i.s.a. was generously provided by Dr. Anita Roberts (NIH) (Sporn et al., 1987) . It was stored at -70°C as a stock solution in 4 mM-HCI/BSA (1 mg/ml) at a concentration of 20 ng/ml and was used within 1 week after defrosting. EGF, PDGF-AB and goat polyclonal anti-PDGF-AB were obtained from Collaborative Research. PDGF-BB was obtained from Amgen.
Cells and cell culture
Hepatic Ito cells were isolated from Sprague-Dawley male rats (> 500 g) by previously described methods (Davis et al., 1987) . The cells were subsequently subcultured (two passages) on tissueculture flasks pre-coated with calf type I collagen as previously described (Davis, 1988; Davis et al., 1987 (Davis, 1988; Davis & Vucic, 1988) . In addition, parallel cultures were exposed to similar conditions in the presence of hydroxyurea to determine the contribution of DNA repair to apparent DNA synthesis (McGowan etal., 1981) . This latter contribution was generally <5% of the total counts.
To assess further the alterations in cell proliferation, labelling of nuclei in situ was performed by using the bromodeoxyuridine (BrdU) labelling method of Muir et al. (1990) , with minor changes. This technique has a high correlation with other measures of cell proliferation in vitro and in vivo (Humes & Thompson, 1989) . In brief, quiescent Ito cells were exposed to retinoic acid, TGF/, or diluent alone for 24 h, followed by PDGF-BB(16 ng/ml) or 10 % fetal-calf serum in the presence of 2.5 ,uM-BrdU for an additional 24 h. The cells were then washed and fixed in 75% (v/v) ethanol and exposed to 2 M-HCl at 37°C for 15 min as described by Muir et al. (1990) . BrdU-labelled nuclei were detected immunohistochemically by using a rat monoclonal anti-BrdU (Accurate Scientific) antibody, followed by a biotinylated rabbit anti-rat IgG secondary antibody (Vector) and the avidin-biotin-peroxidase complex (Vector). The final brown/black reaction product was produced by using a mixture of diaminobenzidine (0.4 mg/ml), H202 (0.01 %), nickel ammonium sulphate (0.016%) and CoCl2 (0.02%) (Harms et al., 1987) . Light nuclear counterstaining was performed with dilute Toluidine Blue (Muir et al., 1990 ).
Modulation of TGF/I production
Confluent monolayers of early-passage Ito cells were incubated in tissue-culture media containing 0.4% fetal-calf serum for 48 h. During the final 24 h, the cells were exposed to PDGF-AB (8 ng/ml) or an equivalent amount of Dulbecco's minimal essential medium (DMEM) diluent. The medium was subsequently collected and stored at -70°C prior to assay. TGFfl was quantified by e.l.i.s.a. as described in detail previously and expressed as pg/well (Davis et al., 1990) . The rabbit polyclonal anti-TGFfl antiserum used in the development of the e.l.i.s.a. was kindly provided by Dr. A. B. Roberts and Dr. D. Danielpour (NIH) (Danielpour et al., 1989) . Parallel curves were routinely obtained for the standard curve of TGF/? and serial dilutions of the Ito-cell culture media.
Assessment of PDGF-receptor abundance and phosphorylation
Sub-confluent cultures of Ito cells or Swiss 3T3 cells on 25 cm2
flasks (precoated with type 1 collagen for Ito-cell culture) were pre-treated for 24 h with retinoic acid, TGFfl or a diluent control as described above in the presence of media containing 0.4 % serum. When the acute effects of PDGF exposure were assessed, the cell medium was replaced with fresh medium (lacking retinoic acid or TGF,) containing PDGF-BB (8 ng/ml) for the final 15 min. The medium was then removed and the cells were scraped directly into solubilization buffer (4% SDS/10 % glycerol/50 mM-Tris/HCl, pH 6.8), heated at 95°C for 3 min and frozen at -70°C. Samples were mixed with dithiothreitol (final concn. 10 mM), heated to 95°C and subjected to electrophoresis and electroblotted on to polyvinylidene difluoride membranes (Immobilon; Millipore, Bedford, MA, U.S.A. (Yarden & Ullrich, 1988) . In addition, the accumulated evidence suggests that it shares the same cell surface receptor as TGF-a, a cytokine which has previously been shown to stimulate Ito-cell proliferation and which has been strongly implicated as an important growth stimulant in vivo during hepatic regeneration (Mead & Nelson, 1989 understanding of their interactions in incomplete (Braun et al., 1988; Russell et al., 1988) . Previous work has shown that TGF/ up-regulates Ito-cell type I collagen production and causes marked inhibition of Ito-cell proliferation when the cells were maintained on either an interstitial matrix of type I collagen or the basement-membrane-like matrix of type IV collagen (Davis, 1988 (Russell et al., 1988) . Visual confirmation of the [3H]thymidine-incorporation experiments was obtained by the use of BrdU labelling of Ito-cell nuclei, as previously described (Muir et al., 1990) . As shown in Fig. 1 , baseline BrdU incorporation was increased by adding either PDGF-BB or 10 % fetal-calf serum, but the former effect was abolished by treatment with either retinoic acid or TGF,. Parallel cultures which lacked BrdU failed to demonstrate any positive nuclear staining (results not shown).
Since preliminary work in other cell systems suggested that the abundance of TGF/, mRNA can be transiently elevated by PDGF exposure, the potential modulation of TGF,8 production by PDGF was considered (Pierce et al., 1989a,b) . It was found (Fig. 2) that a 24 h exposure of quiescent Ito cells (in 0.4% serum) to PDGF-AB (12.5 ng/ml) resulted in a 25 % increase Vol. 278 . Recent studies quantifying TGFfl via receptorcompetition assays confirm the Ito cell's ability to produce latent TGFf, which is biologically active after acid activation (Meyer et al., 1990) . This observation suggests the possibility that Ito cells have the capacity to up-regulate TGF,B production in response to mitogenic peptides. The biological relevance of this observation remains speculative, but evidence from other systems involving mesenchymal-cell proliferation suggests that the temporal pattern of PDGF and TGF/ accumulation may contribute to the formation of the cirrhotic nodule by both initiating and limiting mitogenesis as well as regulating the excessive production of interstitial collagen (Pierce et al., 1989a,b) .
To consider further the cell-specific nature of the observed modulations of PDGF responsiveness, Swiss 3T3 cells grown on tissue-culture plastic were also pretreated with either retinoic acid or TGFfl, and [3H]thymidine incorporation was determined.
Since their inherent proliferative capacity is much greater than that of Ito cells, the cells were initially maintained for 24 h in serum-free media in the absence or presence of retinoic acid or TGFfl. The cells were then exposed to PDGF-BB for 24 h in serum-free media, and during the final 2 h of incubation whereas retinoic acid pre-treatment had no apparent effect [retinoic acid/PDGF-BB 85 + 9 (fold change versus hydroxyurea control)]. Ito cells have previously been shown to contain high concentrations of cytoplasmic retinoid-binding proteins, and it is possible that differences in the expression of cytoplasmic or nuclear retinoic acid-binding proteins underlie the observed differences between these two cell types (Blomhoff et al., 1985) . These studies raise the possibility that retinoic acid may function by modulating common factors which are critical in the overall Ito-cell mitogenic response, and re-emphasize its importance as an appropriate tool for further dissecting the cytokine mitogenic process. This work also emphasizes the functional differences between Ito cells and widely studied fibroblast cell lines, and suggests that the numerous biological observations made with these latter cell types may be difficult to extrapolate to Ito-cell behaviour.
Alterations in Ito-cell activation Since accumulating evidence suggests that the pathologically activated Ito cell is characterized by smooth-muscle a-actin expression and PDGF-receptor expression, it was considered that these two central features might be altered by the various pre-treatments. As shown in Fig. 3(a) , retinoic acid treatment caused no change in the abundance of the PDGF, receptor, whereas TGF,f treatment decreased its abundance. Densitometric scanning of blots from three similar experiments adjusted for differences in protein loading confirmed this observation [(relative units) control 99 + 4*; TGF,8 58 + 7*; retinoic acid 102 + 20 (*P < 0.00 1)]. Western blotting failed to detect an Ito-cell PDGFa receptor, though Swiss 3T3 controls demonstrated a band in the reported (185 kDa) molecular mass for this receptor (results not shown). It is possible that Ito cells express low levels of the PDGF-a receptor below the limits of detection for this Westernblotting technique, and this would be consistent with the limited Ito-cell mitogenic response to PDGF-AA (which requires a PDGF-a receptor) versus either PDGF-AB or PDGF-BB (Pinzani et al., 1990) . Fig. 3(b) similarly demonstrated that retinoic acid caused no change in the abundance of the smoothmuscle a-actin activation marker, whereas TGF,8 caused a slight decrease in its abundance.
Although other studies have noted alterations in PDGFreceptor abundance primarily through receptor-binding studies, it is unclear whether the TGFfl-induced decrease in PDGF,freceptor protein and the modest decrease in a-actin protein observed in the present study are sufficient to account for its marked inhibition of Ito-cell proliferation after PDGF-induced activation (Gronwald et al., 1989) . The relative affinity of the PDGF receptor was not assessed in the current study, owing to inconsistencies observed in PDGF binding during collagencoated-plate assays.
Further studies are needed to determine whether the proximal events surrounding secondary messenger activation are altered or whether the dominant effects of retinoic acid and TGFfl relate to other distal or nuclear-associated events.
